Citation: | Wang Xiliang, Cai Zhiming, Mou Lisha. Research progress of microRNA in diagnosis of diabetes mellitus and monitoring of islet transplant allograft[J]. ORGAN TRANSPLANTATION, 2018, 9(1): 79-82. doi: 10.3969/j.issn.1674-7445.2018.01.012 |
[1] |
ROEP BO, PEAKMAN M. Antigen targets of type 1 diabetes autoimmunity[J]. Cold Spring Harb Perspect Med, 2012, 2(4): a007781. DOI: 10.1101/cshperspect.a007781.
|
[2] |
KAHN SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes[J]. Diabetologia, 2003, 46(1): 3-19. DOI: 10.1007/s00125-002-1009-0.
|
[3] |
KIM VN. MicroRNA biogenesis:coordinated cropping and dicing[J]. Nat Rev Mol Cell Biol, 2005, 6(5): 376-385. DOI: 10.1038/nrm1644.
|
[4] |
BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297. doi: 10.1016/S0092-8674(04)00045-5
|
[5] |
PILLAI RS, ARTUS CG, FILIPOWICZ W. Tethering of human ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis[J]. RNA, 2004, 10(10): 1518-1525. DOI: 10.1261/rna.7131604.
|
[6] |
DING XC, GROSSHANS H. Repression of C. elegans microRNA targets at the initiation level of translation requires GW182 proteins[J]. EMBO J, 2009, 28(3): 213-222. DOI: 10.1038/emboj.2008.275.
|
[7] |
BEHM-ANSMANT I, REHWINKEL J, DOERKS T, et al. mRNA degradation by miRNAs and GW182 requires both CCR4: not dea denylase and DCP1:DCP2 decapping complexes[J]. Genes Dev, 2006, 20(14): 1885-1898. DOI: 10.1101/gad.1424106.
|
[8] |
张许, 朱云霞, 韩晓, 等.MiRNA-24、miRNA-34 a和miRNA-375抑制小鼠胰岛β细胞系MIN6细胞中Neurod1/BETA2的蛋白表达[J].医学分子生物学杂志, 2015, 12(4): 197-201. DOI: 10.3870/j.issn.1672-8009.2015.04.003.
ZHANG X, ZHU YX, HAN X, et al. MiRNA-24、miRNA-34 a and miRNA-375 repress Neurod1/BETA2 protein expression in MIN6 cells[J]. J Med Mol Biol, 2015, 12(4): 197-201. DOI: 10.3870/j.issn.1672-8009.2015.04.003.
|
[9] |
程玉龙. MiR-221/222调控胰岛β细胞增殖和功能的机制研究[D]. 中国科学院大学, 2015.
|
[10] |
柳岚, 桑丹, 曾玲, 等.MiR-26a调控Sox6和Bhlhe22表达对胰岛素分泌的影响[J].中国社区医师, 2016, 32(34): 7-8. DOI: 10.3969/j.issn.1007-614x.2016.34.1.
LIU L, SANG D, ZENG L, et al. Effects of Sox6 and Bhlhe22 expression controlled by miR-26a on insulin secretion[J]. Chin Community Doc, 2016, 32(34): 7-8. DOI: 10.3969/j.issn.1007-614x.2016.34.1.
|
[11] |
KELLER DM, MCWEENEY S, ARSENLIS A, et al. Characterization of pancreatic transcription factor pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy[J]. J Biol Chem, 2007, 282(44): 32084-32092. DOI: 10.1074/jbc.M700899200.
|
[12] |
DUMORTIER O, VAN OBBERGHEN E. MicroRNAs in pancreas development[J]. Diabetes Obes Metab, 2012, 14 (Suppl 3): 22-28. DOI: 10.1111/j.1463-1326.2012.01656.x.
|
[13] |
SONG SD, ZHOU J, ZHOU J, et al. MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma[J]. Oncol Lett, 2013, 6(4): 953-959. DOI: 10.3892/ol.2013.1510.
|
[14] |
PLAISANCE V, ABDERRAHMANI A, PERRET-MENOUD V, et al. MicroRNA-9 controls the expression of granuphilin/slp4 and the secretory response of insulin-producing cells[J]. J Biol Chem, 2006, 281(37): 26932-26942. DOI: 10.1074/jbc.M601225200.
|
[15] |
LOVIS P, GATTESCO S, REGAZZI R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs[J]. Biol Chem, 2008, 389(3): 305-312. DOI: 10.1515/BC.2008.026.
|
[16] |
WIJESEKARA N, ZHANG LH, KANG MH, et al. MiR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets[J]. Diabetes, 2012, 61(3): 653-658. DOI: 10.2337/db11-0944.
|
[17] |
姬海玉. 高表达microRNA-126诱导INS-1细胞凋亡的研究[D]. 宁夏医科大学, 2014. DOI: 10.7666/d.D585970.
|
[18] |
陈玮. MiR-29a调控Mcl-1介导内质网应激对胰岛β细胞凋亡的影响[D]. 南京医科大学, 2015.
|
[19] |
NIETO M, HEVIA P, GARCIA E, et al. Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds[J]. Cell Transplant, 2012, 21(8): 1761-1774. DOI: 10.3727/096368911X612521.
|
[20] |
MELKMAN-ZEHAVI T, OREN R, KREDO-RUSSO S, et al. MiRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors[J]. EMBO J, 2011, 30(5): 835-845. DOI: 10.1038/emboj.2010.361.
|
[21] |
MAS VR, DUMUR CI, SCIAN MJ, et al. MicroRNAs as biomarkers in solid organ transplantation[J]. Am J Transplant, 2013, 13(1): 11-19. DOI: 10.1111/j.1600-6143.2012.04313.x.
|
[22] |
KANAK MA, TAKITA M, SHAHBAZOV R, et al. Evaluation of microRNA375 as a novel biomarker for graft damage in clinical islet transplantation[J]. Transplantation, 2015, 99(8): 1568-1573. DOI: 10.1097/TP.0000000000000625.
|
[23] |
WANG J, YE H, ZHANG D, et al. MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer[J]. Cancer Cell Int, 2016, 16: 12. DOI: 10.1186/s12935-016-0285-6.
|
[24] |
WIDODO, DJATI MS, RIFA'I M. Role of microRNAs in carcinogenesis that potential for biomarker of endometrial cancer[J]. Ann Med Surg (Lond), 2016, 7:9-13. DOI: 10.1016/j.amsu.2016.01.091.
|
[25] |
SHAN J, FENG L, LUO L, et al. MicroRNAs: potential biomarker in organ transplantation[J]. Transpl Immunol, 2011, 24(4): 210-215. DOI: 10.1016/j.trim.2011.03.004.
|
[26] |
ANGLICHEAU D, SHARMA VK, DING R, et al. MicroRNA expression profiles predictive of human renal allograft status[J]. Proc Natl Acad Sci USA, 2009, 106(13): 5330-5335. DOI: 0.1073/pnas.0813121106.
|
[27] |
BHATT K, MI QS, DONG Z. MicroRNAs in kidneys:biogenesis, regulation, and pathophysiological roles[J]. Am J Physiol Renal Physiol, 2011, 300(3): F602-F610. DOI: 10.1152/ajprenal.00727.2010.
|
[28] |
伍仙凤, 李书国, 盛德乔, 等.MiRNA与糖尿病及其并发症的研究进展[J].实用医学杂志, 2014, 30(7): 1036-1038. DOI: 10.3969/j.issn.1006-5725.2014.07.009.
WU XF, LI SG, SHENG DQ, et al. Research progress of miRNA and diabetes mellitus and its complications[J]. J Pract Med, 2014, 30(7): 1036-1038. DOI: 10.3969/j.issn.1006-5725.2014.07.009.
|
[29] |
ERENER S, MOJIBIAN M, FOX JK, et al. Circulating miR-375 as a biomarker of β-cell death and diabetes in mice[J]. Endocrinology, 2013, 154(2): 603-608. DOI: 10.1210/en.2012-1744.
|
[30] |
NIELSEN LB, WANG C, SØRENSEN K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls:evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression[J]. Exp Diabetes Res, 2012: 896362. DOI: 10.1155/2012/896362.
|
[31] |
SALAS-PÉREZ F, CODNER E, VALENCIA E, et al. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes[J]. Immunobiology, 2013, 218(5): 733-737. DOI: 10.1016/j.imbio.2012.08.276.
|
[32] |
聂培培, 宫雅南.Hsa-miR-1249和hsa-miR-486-5p与Ⅱ型糖尿病的相关性研究[J].激光生物学报, 2016, 25(3): 240-243. DOI: 10.3969/j.issn.1007-7146.2016.03.009.
NIE PP, GONG YN. Relationship between hsa-miR-1249 and has-miR-486-5p and type 2 diabetes[J]. Acta Laser Biol Sinica, 2016, 25(3): 240-243. DOI: 10.3969/j.issn.1007-7146.2016.03.009.
|
[33] |
徐志伟, 孙晓彤.检测血清microRNA对糖尿病诊断的潜在价值[J].临床检验杂志, 2012, 30(9): 656-658. DOI: 10.13602/j.cnki.jcls.2012.09.007.
XU ZW, SUN XT. The potential value of detection of serum microRNA for diagnosis of diabetes[J]. Chin J Clin Lab Sci, 2012, 30(9): 656-658.DOI: 10.13602/j.cnki.jcls.2012.09.007.
|
[34] |
晏少颖. 糖尿病前期和2型糖尿病患者血浆中差异表达microRNAs的筛选及临床诊断价值研究[D]. 贵州医科大学, 2016.
|
[35] |
KONG L, ZHU J, HAN W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study[J]. Acta Diabetol, 2011, 48(1):61-69. DOI: 10.1007/s00592-010-0226-0.
|
[36] |
梁国威, 宋燕, 邵冬华, 等.初诊2型糖尿病患者血清中miR-29a和miR-375表达变化及其与糖、脂标志物相关性研究[J].中国实验诊断学, 2013, 17(3): 475-478. DOI: 10.3969/j.issn.1007-4287.2013.03.018.
LIANG GW, SONG Y, SHAO DH, et al. The change of serum miR-375 and miR-29a and their correlation with glycemic control and lipid profile in patients with newly diagnosed type 2 diabetes[J]. Chin J Lab Diagn, 2013, 17(3): 475-478. DOI: 10.3969/j.issn.1007-4287.2013.03.018.
|
[37] |
RONG Y, BAO W, SHAN Z, et al. Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus[J]. PLoS One, 2013, 8(9): e73272. DOI: 10.1371/journal.pone.0073272.
|
[38] |
ZAMPETAKI A, KIECHL S, DROZDOV I, et al. Plasma microRNA profiling reveals loss of end othelial miR-126 and other microRNAs in type 2 diabetes[J]. Circ Res, 2010, 107(6): 810-817. DOI: 10.1161/CIRCRESAHA.110.226357.
|
[39] |
胥娟. 利拉鲁肽对初诊2型糖尿病患者血清miRNA表达谱的影响[D]. 东南大学, 2016. http://www.bigengculture.com/yixuelunwen/nfm/974028.html
|
[40] |
ZHAO C, DONG J, JIANG T, et al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus[J]. PLoS One, 2011, 6(8): e23925. DOI: 10.1371/journal.pone.0023925.
|
[41] |
王维.异种胰岛移植研究现状和走向临床的关键科学问题[J].器官移植, 2017, 8(6): 413-416. DOI: 10.3969/j.issn.1674-7445. 2017.06.001.
WANG W. Research status of islet xenotransplantation and key scientific problems toward clinic[J]. Organ Transplant, 2017, 8(6): 413-416. DOI: 10.3969/j.issn.1674-7445. 2017.06.001.
|
[42] |
ZHAO W, LIU W, TIAN D, et al. WapRNA: a web-based application for the processing of RNA sequences[J]. Bioinformatics, 2011, 27(21): 3076-3077. DOI: 10.1093/bioinformatics/btr504.
|
[43] |
KOZOMARA A, GRIFFITHS-JONES S. MiRBase:annotating high confidence microRNAs using deep sequencing data[J]. Nucleic Acids Res, 2014, 42: D68-D73. DOI: 10.1093/nar/gkt1181.
|